Skip to Main content Skip to Navigation
Journal articles

Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.

Abstract : Mutations in factor H (CFH), factor I (IF), and membrane cofactor protein (MCP) genes have been described as risk factors for atypical hemolytic uremic syndrome (aHUS). This study analyzed the impact of complement mutations on the outcome of 46 children with aHUS. A total of 52% of patients had mutations in one or two of known susceptibility factors (22, 13, and 15% of patients with CFH, IF, or MCP mutations, respectively; 2% with CFH+IF mutations). Age <3 mo at onset seems to be characteristic of CFH and IF mutation-associated aHUS. The most severe prognosis was in the CFH mutation group, 60% of whom reached ESRD or died within <1 yr. Only 30% of CFH mutations were localized in SCR20. MCP mutation-associated HUS has a relapsing course, but none of the children reached ESRD at 1 yr. Half of patients with IF mutation had a rapid evolution to ESRD, and half recovered. Plasmatherapy seemed to have a beneficial effect in one third of patients from all groups except for the MCP mutation group. Only eight (33%) of 24 kidney transplantations that were performed in 15 patients were successful. Graft failures were due to early graft thrombosis (50%) or HUS recurrence. In conclusion, outcome of HUS in patients with CFH mutation is catastrophic, and posttransplantation outcome is poor in all groups except for the MCP mutation group. New therapies are urgently needed, and further research should elucidate the unexplained HUS group.
Document type :
Journal articles
Complete list of metadatas

https://www.hal.inserm.fr/inserm-00409786
Contributor : Marie Francoise Simon <>
Submitted on : Wednesday, August 12, 2009 - 5:10:19 PM
Last modification on : Wednesday, August 19, 2020 - 12:08:05 PM

Links full text

Identifiers

Citation

Anne-Laure Sellier-Leclerc, Veronique Fremeaux-Bacchi, Marie-Agnès Dragon-Durey, Marie-Alice Macher, Patrick Niaudet, et al.. Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.. Journal of the American Society of Nephrology, American Society of Nephrology, 2007, 18 (8), pp.2392-400. ⟨10.1681/ASN.2006080811⟩. ⟨inserm-00409786⟩

Share

Metrics

Record views

798